Alterity Therapeutics Ltd (ATHE)
2.51
+0.25
(+11.06%)
USD |
NASDAQ |
Apr 26, 16:00
2.49
-0.02
(-0.80%)
After-Hours: 20:00
Alterity Therapeutics Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -13.48M |
| March 31, 2023 | 6.522M |
| December 31, 2022 | -6.522M |
| September 30, 2022 | |
| June 30, 2022 | -8.946M |
| March 31, 2022 | 6.316M |
| Date | Value |
|---|---|
| December 31, 2021 | -6.316M |
| September 30, 2021 | |
| December 31, 2019 | -1.767M |
| September 30, 2019 | |
| December 31, 2015 | -5.310M |
| September 30, 2015 | -0.0033M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-13.48M
Minimum
Jun 2023
6.522M
Maximum
Mar 2023
-3.456M
Average
-6.316M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Opthea Ltd | -- |
| Mesoblast Ltd | -16.28M |
| Immuron Ltd | -- |